» Articles » PMID: 12135254

Episodes of Atrial Fibrillation and Atrial Vulnerability After Successful Radiofrequency Catheter Ablation in Patients with Wolff-Parkinson-White Syndrome

Overview
Journal Europace
Date 2002 Jul 24
PMID 12135254
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Episodes of atrial fibrillation occur in patients with WPW syndrome but frequently disappear after successful radiofrequency ablation.

Aims: To analyze the incidence of atrial fibrillation before and after successful ablation and the presence of increased atrial vulnerability.

Methods And Results: Fifty-four of 183 WPW patients had at least one documented episode of atrial fibrillation before ablation. During a follow-up of 24 +/- 12 months 13/54 patients (24%) experienced atrial fibrillation. At baseline, the patients with atrial fibrillation were more often men (74%) vs 53%, P=0.007), were older (45 +/- 15 vs 34 +/- 16 years, P=0.0001), more often had pre-excitation during sinus rhythm (87% vs, 73%, P=0.04) and had increased atrial vulnerability (41%, vs 18%, P<0.001). Only patients with atrial fibrillation before, developed atrial fibrillation after ablation. The 13 (of 54) patients who relapsed were also older (53 +/- 13 vs 42 +/- 15 years, P= 0.03), had increased atrial vulnerability at baseline (77% vs 29%, P=0.002), and were more symptomatic, (13 +/- 21 vs 1 +/- 3 arrhythmia attacks/month, P=0001). No patient without atrial fibrillation before ablation developed atrial fibrillation after treatment.

Conclusions: The accessory pathway was important for the development of atrial fibrillation. Frequent tachycardias seem to promote an electrical remodelling and an increased atrial vulnerability to atrial fibrillation, whereas after successful ablation the majority of patients remain free of atrial fibrillation.

Citing Articles

Effect of pulmonary vein isolation on atrial fibrillation recurrence after accessory pathway ablation in patients with Wolff-Parkinson-White syndrome.

Wu J, Zhao D, Li F, Zhang L, Hu J, Fan X Clin Cardiol. 2020; 43(12):1511-1516.

PMID: 33002216 PMC: 7724218. DOI: 10.1002/clc.23470.


Incidence and Risk Factors for Atrial Fibrillation Recurrence after Ablation of Nodal and Atrioventricular Reentrant Tachycardia: A Meta-analysis.

Torbey E, Karam B, Sleiman E, Tabet R, Kirk M, Donaldson D Cureus. 2020; 12(4):e7824.

PMID: 32467799 PMC: 7249774. DOI: 10.7759/cureus.7824.


Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways.

Chen M, Feng X, Sun J, Wang Q, Zhang P, Wang J Int J Cardiol Heart Vasc. 2017; 7:69-75.

PMID: 28785648 PMC: 5497232. DOI: 10.1016/j.ijcha.2015.02.010.


Assessment of atrial fibrillation and vulnerability in patients with Wolff-Parkinson-White syndrome using two-dimensional speckle tracking echocardiography.

Li J, Wei F, Chen J, Yu Y, Gu H, Jiang R PLoS One. 2014; 9(11):e108315.

PMID: 25397668 PMC: 4232256. DOI: 10.1371/journal.pone.0108315.


Atrioventricular accessory pathway with anterograde decremental conduction property.

Fujita S, Fujii E, Sugiura S, Ito M BMJ Case Rep. 2013; 2013.

PMID: 23780770 PMC: 3702970. DOI: 10.1136/bcr-2013-009814.